Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,062 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American Cohort.
Finati M, Davis M, Stephens A, Chiarelli G, Cirulli GO, Morrison C, Affas R, Sood A, Buffi N, Lughezzani G, Briganti A, Montorsi F, Carrieri G, Rogers C, Vickers AJ, Abdollah F. Finati M, et al. Among authors: morrison c. Eur Urol Oncol. 2024 Jul 10:S2588-9311(24)00172-X. doi: 10.1016/j.euo.2024.06.014. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38991891
Testing the external validity of the POUT III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohort.
Corsi NJ, Stephens A, Finati M, Malchow T, Morrison C, Davis M, Hares K, Corsi MP, Arora S, Chiarelli G, Cirulli GO, Autorino R, Sood A, Rogers C, Abdollah F. Corsi NJ, et al. Among authors: morrison c. Urol Oncol. 2024 Jun;42(6):175.e19-175.e25. doi: 10.1016/j.urolonc.2024.01.035. Epub 2024 Mar 23. Urol Oncol. 2024. PMID: 38522975 Clinical Trial.
Race has no impact on prostate cancer-specific mortality, when comparing patients with similar risk of other-cause mortality: An analysis of a population-based cohort.
Tinsley SA, Finati M, Stephens A, Chiarelli G, Cirulli GO, Williams E, Morrison C, Richard C, Hares K, Sood A, Buffi N, Lughezzani G, Bettocchi C, Salonia A, Briganti A, Montorsi F, Carrieri G, Rogers C, Abdollah F. Tinsley SA, et al. Among authors: morrison c. Cancer. 2024 Sep 15;130(18):3157-3169. doi: 10.1002/cncr.35386. Epub 2024 May 28. Cancer. 2024. PMID: 38804713
Association of race with incidence, characteristics, and mortality from incidental prostate cancer: Analysis of two North American contemporary cohorts.
Finati M, Morrison C, Stephens A, Chiarelli G, Cirulli GO, Tinsley S, Davis M, Sood A, Buffi N, Lughezzani G, Salonia A, Briganti A, Montorsi F, Busetto GM, Bettocchi C, Rogers C, Carrieri G, Abdollah F. Finati M, et al. Among authors: morrison c. Prostate. 2024 Oct 28:e24803. doi: 10.1002/pros.24803. Online ahead of print. Prostate. 2024. PMID: 39465565
Large Incarcerated Inguinal Hernia: A Case Report.
Lutchka JD, Morrison CW, Adjemian AA, Walker PD. Lutchka JD, et al. Cureus. 2022 Aug 9;14(8):e27822. doi: 10.7759/cureus.27822. eCollection 2022 Aug. Cureus. 2022. PMID: 36106211 Free PMC article.
Surgery versus radiation for clinically positive nodal prostate cancer in an other cause mortality risk weighted cohort.
Tinsley SA, Stephens A, Finati M, Chiarelli G, Cirulli GO, Morrison C, Richard C, Hares K, Lutchka J, Sood A, Buffi N, Lughezzani G, Bettocchi C, Salonia A, Briganti A, Montorsi F, Carrieri G, Rogers C, Abdollah F. Tinsley SA, et al. Among authors: morrison c. Int Urol Nephrol. 2024 Nov 11. doi: 10.1007/s11255-024-04253-9. Online ahead of print. Int Urol Nephrol. 2024. PMID: 39528898
2,062 results